Jorda Radek

Journals

JORDA, R., S. KRAJČOVIČOVÁ, P. KRÁLOVÁ, M. SOURAL, V. KRYŠTOF
Scaffold hopping of the SYK inhibitor entospletinib leads to broader targeting of the BCR signalosome. European Journal of Medicinal Chemistry. 2020, 204, 112636, ISSN: 0223-5234, PMID: 32731189,
JORDA, R., P. MAGAR, D. HENDRYCHOVA, K. PAUK, M. DIBUS, E. PILAROVA, A. IMRAMOVSKY, V. KRYŠTOF
Novel modified leucine and phenylalanine dipeptides modulate viability and attachment of cancer cells. European Journal of Medicinal Chemistry. 2020, 188, 112036, ISSN: 0223-5234, PMID: 31931341,
SALAS C., O., A. ZARATE, V. KRYŠTOF, J. MELLA, M. FAUNDEZ, J. BREA, M. LOZA, I. BRITO, D. HENDRYCHOVA, R. JORDA, A. CABRERA, R. TAPIA, C. ESPINOSA-BUSTOS
Promising 2,6,9-Trisubstituted Purine Derivatives for Anticancer Compounds: Synthesis, 3D-QSAR, and Preliminary Biological Assays. International Journal of Molecular Sciences. 2020, 21(1), pii: E161, ISSN: 1422-0067, PMID: 31881717,  PDF.